FirsthandHealth
medRxiv PreprintsInternational16 November 2026

Role of Intravenous Tranexamic Acid in Immediate Breast Reconstruction with an Extended Latissimus Dorsi Flap: A Retrospective Cohort Study

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Background: The purpose of this study was to assess the impact of intravenous tranexamic acid (TXA) on postoperative drainage, laboratory parameters, and complications in patients undergoing immediate extended latissimus dorsi (ELD) flap breast reconstruction. Methods: This retrospective cohort study included 82 patients who underwent immediate ELD flap breast reconstruction between January 2019 and May 2026. The TXA group (n = 42) received 1 g of intravenous TXA at the start of surgery after its routine adoption in July 2021; the control group (n = 40) underwent surgery before this date witho
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.